Complete Coverage
Access public and private biotech and pharma across companies, pipelines, financings, and trials.
Smarter Diligence
Streamline diligence with integrated signals, from catalysts to filings, for faster decision-making.
Actionable Context
Turn data into strategy with executive contacts, partnerships, and regional insights.
​BPIQ APEX Supercharged Features
What makes APEX different — how each feature is elevated
Catalyst Calendar
The Catalyst Calendar is a chronological view of biotech events that could move stock prices, including clinical trials, commercial launches, and regulatory decisions.
Private Trial Data
Expanded with private (and public) company pipeline context, helping investors connect catalysts with broader drug development activity through biopharmIQ's Clinical Trial Module
Big Movers™
The Big Movers™ tool highlights biotech events expected to shift stock prices, based on options data and internal analysis of volatility, suspected movers, and future movers
Funding Signals
Enriched with funding intelligence from biopharmIQ’s Funding Activity module, covering early- and late-stage rounds plus grants, with funding dates, deal details, and product focus to help investors spot future movers early.
PDUFA Events
The PDUFA Calendar tracks FDA target decision dates and advisory meetings for NDA and BLA filings.
Pipeline Insight
APEX includes the full FDA PDUFA calendar and enhances it with biopharmIQ's pipeline intelligence, providing visibility into public and private drug candidates that are progressing toward potential FDA decisions and may advance to the PDUFA stage.
Company Screener
The Company Screener lets you filter and analyze all companies in our database by attributes and drug assets—ideal for uncovering new investment ideas.
Expanded Horizon
Screen over 9,800 public and private bio/pharma companies and connect with 65,000 key contacts to uncover opportunities others miss.
M&A Activity
BPIQ tracks mergers and acquisitions among smid-cap biopharma, including deal volume, size, acquirers, and therapeutic focus.
Deal Intelligence
Turn deal activity into intelligence. Use company screener, funding data, and trial data to spot targets and anticipate the next M&A wave.
Hedge Fund Screener
The Hedge Fund Screener tracks quarterly 13F filings from leading biotech hedge funds, revealing holdings, performance, and investor moves.
Crossover Insight
Use hedge fund holdings as a starting point. Then go deeper with biopharmIQ. Connect filings to pipeline progress, financing activity, and company fundamentals to uncover hidden signals behind fund positions.
Analysts & Portfolios
Access analyst ratings and consensus
Pipeline Context
APEX connects analyst forecasts with actual investigational pipeline strength and breadth.
All the power of BPIQ, amplified with biopharmIQ.
Powered by
Who benefits from APEX
From institutional investors to crossover funds, APEX delivers the insights you need.
Institutional Investors
Benchmark public companies while scouting potential private IPO candidates.
Equity Analysts & Researchers
Connect financial signals with R&D activity and trial progress.
Crossover & VC Funds
Spot pre-IPO winners, map partnerships, and assess momentum.
Your workflow, supercharged
See how APEX transforms your research process from start to finish.
1
Start with a public company
Begin with a company on your watchlist
2
Explore related players
Open related private players, pipelines, & trials
3
Layer in funding data
Add funding and M&A signals to spot momentum.
4
Access key contacts
Access 65,000+ verified contacts for outreach.
5
Insight to Impact
Save, share, and act to stay ahead.
See exactly what APEX adds to your BPIQ foundation.
BPIQ vs BPIQ APEX
FEATURE
BPIQ
BPIQ APEX
Enhanced
Catalyst Calendar
​​
​​​​​
Big Movers™
​​​​
​​​​​
PDUFA Events
​​​​​​
​​​
Company Screener
​​​​
​​​​​
M&A Activity
​​​​
​​​​​
Hedge Fund Screener
​​​​
​​​​​
Analysts & Portfolios
Public catalysts (clinical, commercial, FDA)
​
​​​
Stock movers from options & analysis
​​
​​​
FDA target decision dates & advisory meetings
​​
​​​
Public company database with filters
​​
​​​
Public smid-cap M&A tracking
​​
​​​
13F filings for top biotech hedge funds
​​
​​​
Public analyst ratings & benchmarking
Expanded with private pipeline context
​
​​​​
Enriched with private funding signals
​​​
​​​
Extended to global milestones + private data
​​​
​​​
Broadened to 9,800+ private & public co.
​​
​​​​
Enhanced with licensing & partnership intel
​​
​​​​
Unlocks crossover insights on private deals​​
​
​
Includes trend reports & industry insights